| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.4 (Beat by $0.2) |
| EPS GAAP Actual | $0.4 (Beat by $0.2) |
| Revenue Actual | $1.944B |
| Revenue Surprise | Beat by $1944M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.30308 |
| EPS GAAP Estimate | $0.30308 |
| Revenue Estimate | $1.903014583B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.05 | 23.05 | 0.8442 | 1.30015 | 1 |
| Dec 2028 | 1.1 | 22 | 0.96661 | 1.25454 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.72 | 2.92432 | 1.944B | 5.71% | 42.65M |
| FQ2 2025 (Jun 2025) | -1.14 | -1.8185 | 1.761B | -11.7% | -127.35M |
| FQ1 2025 (Mar 2025) | -1.22 | -1.22 | 1.646B | -13.18% | 1646M |
| FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 1.947B | -13.1% | 1947M |
| FQ3 2024 (Sep 2024) | -1.23 | -1.23 | 1.833B | -37.59% | 1833M |
| FQ2 2024 (Jun 2024) | 0.21 | 0.21 | 1.967B | -13.68% | 1967M |
| FQ1 2024 (Mar 2024) | 0.82 | 0.82 | 1.863B | -22.71% | 1863M |
| FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 2.202B | -21.71% | 2202M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.30308
Consensus Revenue Estimates
1.903014583B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.020686 | -- | -0.02595284 | -0.01584335 | 2 |
| FQ3 2027 (Sep 2027) | 0.19124 | -- | 0.12945 | 0.31191 | 1 |
| FQ2 2027 (Jun 2027) | 0.18457 | -- | 0.12494 | 0.30103 | 1 |
| FQ1 2027 (Mar 2027) | 0.18913 | -- | 0.12802 | 0.30847 | 1 |
| FQ4 2026 (Oct 2026) | 0.65583 | -- | 0.56975 | 0.74314 | 1 |
| FQ3 2026 (Jul 2026) | 0.68034 | -446.79 | 0.59105 | 0.77091 | 1 |
| FQ2 2026 (Jun 2026) | 0.76291 | 249.43 | 0.67977 | 0.87137 | 1 |
| FQ1 2026 (Mar 2026) | 0.30308 | 502.53 | 0.30308 | 0.30308 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.89B | -- | 1.55B | 2.26B | 2 |
| FQ3 2027 (Sep 2027) | 1.87B | -- | 1.41B | 2.78B | 2 |
| FQ2 2027 (Jun 2027) | 1.85B | -- | 1.39B | 2.75B | 2 |
| FQ1 2027 (Mar 2027) | 1.84B | -- | 1.38B | 2.73B | 2 |
| FQ4 2026 (Oct 2026) | 1.94B | -- | 1.74B | 2.14B | 1 |
| FQ3 2026 (Jul 2026) | 1.93B | -0.55 | 1.74B | 2.13B | 1 |
| FQ2 2026 (Jun 2026) | 1.93B | 8.92 | 1.77B | 2.14B | 1 |
| FQ1 2026 (Mar 2026) | 1.9B | 13.51 | 1.9B | 1.9B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.79568 | 3.72 | 2.92432 | 78.61% |
| FQ2 2025 (Jun 2025) | 0.6785 | -1.14 | -1.8185 | 159.52% |
| FQ1 2025 (Mar 2025) | -1.22 | -1.22 | 100% | |
| FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 100% | |
| FQ3 2024 (Sep 2024) | -1.23 | -1.23 | 100% | |
| FQ2 2024 (Jun 2024) | 0.21 | 0.21 | 100% | |
| FQ1 2024 (Mar 2024) | 0.82 | 0.82 | 100% | |
| FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.9B | $1.94B | $42.65M | 2.19% |
| FQ2 2025 (Jun 2025) | $1.89B | $1.76B | $-127.35M | -7.23% |
| FQ1 2025 (Mar 2025) | $0B | $1.65B | $1646M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.95B | $1947M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.83B | $1833M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.97B | $1967M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.86B | $1863M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.2B | $2202M | 100% |